Pediatric decision limits for serologic screening of lyme disease

CONCLUSIONS: Our modified ranges are more suitable for our pediatric population while reducing overdiagnosis, unnecessary treatment, diagnostic uncertainty, and turnaround time.PMID:33617846 | DOI:10.1016/j.clinbiochem.2021.02.005

Source: Clinical Biochemistry - February 22, 2021 Category: Biochemistry Authors: Oscar Lopez-Nunez Pooja Srivastava Bradley J Wheeler Nicole Oakes Holly Thomas Andrew Nowalk Sarah Wheeler Source Type: research